Catherine Allison Stewart

This study shows DLL3 expression level predicts response and long-term survival in SCLC patients treated with tarlatamab.

This study identifies YAP1-positive cells in relapsed SCLC that exhibit drug tolerance and transition from SCLC to LCNEC-like features, losing some targets but gaining others.

This study uses CyTOF to profile circulating tumor cells in SCLC patients, identifying subtype-specific markers and treatment response correlations.

This study identifies three distinct DDR phenotypes in SCLC associated with chemotherapy response and tumor evolution.

This study shows that chronic estrus, caused by disrupted gonadotropin-releasing hormone signaling, leads to uterine gland pathologies in female mice.

The paper develops a 3D staging system for mouse uterine gland morphogenesis from P0 to P21, identifying six stages and describing morphological changes over time.